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Objectives: Chikungunya (CHIK) has been classified as a communicable disease
group IV in South Korea since late 2010. Based on this, we investigated the extent
of imported cases of CHIK in dengue-suspected individuals returning from
dengue-endemic regions.
Methods: A total of 486 dengue-suspected serum samples were screened for CHIK
by enzyme-linked immunosorbent assay (ELISA) and reverse transcription-
polymerase chain reaction (RT-PCR) analysis. Further RT-PCR-positive samples
were used for the viral culture, and CHIK was subsequently confirmed by
sequence analysis of the culture samples.
Results: Five out of 107 dengue-positive samples were found to be positive for
CHIK and 15 out of 379 dengue-negative samples were found to be positive for
CHIK by immunoglobulin M ELISA. Further, a CHIK virus was isolated from one of
the two RT-PCR-positive sera by cell culture and confirmed by sequence analysis.
Conclusion: The present study documents the first evidence of travel-associated
CHIK infection in South Korea. Considering the intense international traffic be-
tween countries, our finding emphasizes the urgent need for active patient and
vector surveillance for timely response to reduce the introduction of CHIK in Korea.1. Introduction
Chikungunya (CHIK) is a mosquito-borne febrile
disease caused by the chikungunya virus (CHIKV),
which belongs to the genus Alphavirus of the Togavir-
idae family [1]. The CHIKV has a single-stranded,
positive-sense RNA genome, which consists of 50-
nsP1-nsP2-nsP3-nsP4-junction region-C-E3-E2-6K-E1-
poly (A)-30 [2]. The virus was first isolated from ated under the terms of the
) which permits unrestrict
operly cited.
ase Control and Preventionfebrile patient in Tanzania in 1953 and spread into
Africa, Pacific, and South East Asian regions [3,4,5].
The virus has now been transmitted to more than 20
countries and is one of the most potential risks among
the travel-associated diseases for travelers to tropical
regions [6,7,8]. Since its re-emergence in the Indian
Ocean Island in 2005, the virus was recognized as a
global public health threat [9]. Three genotypes of
CHIKV have been characterized based on their partialCreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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African, and West African genotypes [10].
The CHIKV is transmitted to humans mainly by
Aedes aegypti and Aedes albopictus mosquitoes. Clin-
ical symptoms also resemble dengue, which include
chills, fever, headache, myalgia, nausea, vomiting, and
rashes [11]. In addition, overlap of disease-occurrence
areas make it difficult to identify the exact pathogens
involved, if the differential diagnostic methods are un-
available. In South Korea, dengue diagnosis began in
2001 at the Korea National Institute of Health (KNIH)
and since then imported cases have been continuously
reported [12,13]. Because no vaccines or therapeutic
agents are available, early detection of the virus is
important for timely vector control and prevention of
viral dissemination into nonendemic regions. To cope
with an abrupt re-emergence of CHIK in South East
Asian regions, the Korean government designated CHIK
as a communicable disease group IV in late 2010.
However, before enacting this law, it was necessary to
estimate the occurrence of CHIK cases introduced by
patients with dengue-like diseases who had returned
from dengue-endemic regions. In the present study, we
first documented the travel-associated introduction of
CHIKV into South Korea during 2009e2010, which
stresses the importance of making modifications to the
travel health policies.Figure 1. Detection of chikungunya virus (CHIKV) from a
patient’s serum by duplex reverse transcription-polymerase
chain reaction targeting both CHIKV and dengue virus
(DENV). Lane 1, patient code 09-B09; lane 2, patient code 09-
B36; lane 3, positive control (DENV), lane M, 1kb DNA
ladder. The expected size of CHIKV and DENV fragment was
205 and 511 bp, respectively.2. Materials and Methods
2.1. Serum samples
A total of 873 serum samples were sent to the Di-
vision of Arboviruses at the KNIH for dengue diagnosis
during 2009e2010. Among them 486 serum samples
were tested for CHIK, in which 107 and 379 sera were
positive and negative for dengue immunoglobulin M
(IgM), respectively. This study was conducted as a
routine laboratory diagnosis and did not require either
informed consent or institutional review.
2.2. IgM enzyme-linked immunosorbent assay
All the collected serum samples were tested for the
presence of CHIKV-specific IgM antibodies using the
commercial enzyme-linked immunosorbent assay
(ELISA) kit (NovaTec, Germany) according to the
manufacturer’s instruction. Based on absorbance at
450 nm, the NovaTec Units (NTUs) were calculated for
each sample and samples having NTU > 11 were
considered positive.
2.3. Multiplex reverse transcription-polymerase
chain reaction
The viral RNA was extracted from serum samples by
Viral Gene-spin DNA/RNA extraction kit (iNtRON
Biotechnology, Gyeonggi-do, Korea) according to the
manufacturer’s protocol. The isolated RNA was reversetranscribed and amplified according to the one-step
duplex reverse transcription-polymerase chain reaction
(RT-PCR) assay developed for differential diagnosis of
DENV and CHIKV [14]. In brief, two primer pairs
(CHIK1 and 2, DEN1 and 2) targeting the CHIKV E1
gene and DENV C/prM gene were incorporated into the
reaction and the exact pathogen was determined based
on the fragment size (CHIKV: 205 bp; DENV: 511 bp).
To exclude cross contamination by laboratory-reference
CHIKV strain, we used DENV as a positive control in
the RT-PCR assay (Figure 1). Further confirmation was
achieved by PCR direct sequencing using the primers
CHIK1 and CHIK2 (Macrogen, Seoul, Korea).
2.4. Virus isolation
Virus isolation from RT-PCR-positive serum was
attempted using invertebrate C6/36 cells (ATCC, CRL
1660). Approximately 1 mL of 20-fold diluted serum
was inoculated into C3/36 cells cultured in a 25-cm2
culture flask with minimal essential medium containing
5% fetal bovine serum and antibiotics. After absorption
for 1 hour, the cells were washed once with phosphate-
buffered saline and incubated at 28C in a humidified
CO2 incubator. The culture supernatant was collected
7 days after infection, clarified by brief centrifugation,
and stored as small aliquots at 70C for further anal-
ysis. The presence of virus in the culture supernatant
was confirmed by RT-PCR and sequence analysis.
2.5. Nucleotide sequencing and phylogenetic
analysis
The culture supernatant confirmed as CHIKV was
further amplified using three primer pairs (9648F/
10403R, 10145F/11158R, and 10959F/11770R)
encompassing E2, E1, and 30NC [15]. The RT-PCR
analysis was performed using the SuperScript III first-
strand synthesis system (Invitrogen, Carlsbad, CA,
USA) and DyNAzyme EXT DNA polymerase
172 G.W. Cha, et al(Thermo). The resulting nucleotide sequences were
assembled using the SeqMan program in the Lasergene
software (version 8; DNASTAR, Madison, WI, USA)
and the final sequence (approximately 1.9 kb in length)
was identified by NCBI-BLAST search. Nucleotide
sequences of 1044-nt long E1 partial genes from
21CHIKV isolates were selected for sequence compar-
ison and phylogenetic analysis. Nucleotide and amino-
acid sequences were aligned by CLUSTAL W algo-
rithm using the BioEdit software (version 7.0). The
neighbor-joining algorithm and the maximum composite
likelihood model were used for tree construction by
MEGA software (version 5.1) [16]. The reliability of the
analysis was evaluated by a bootstrap test with 2000
replications. The o’nyong-nyong virus (GenBank ID:
AF079456) was used as out-group in the tree.3. Results
3.1. Laboratory testing
A total of 488 serum samples were tested for CHIKV
infection. The results were summarized in Table 1 and
Figure 1. Twenty serum samples were found to be
ELISA positive and two serum samples were RT-PCR
positive. It is notable that five cases were IgM positive
for both CHIKV and DENV. Age distribution of CHIK-
positive cases was four in teens, one in 20s, seven in
30s, one in 40s, two in 50s, one in 70s, and five cases areTable 1. Result of laboratory testing for Chikungunya
Patient ID Age
Days after
Dengue
Onset* ELISA RT-P
09-A37 IUy IU e e
09-A63 33 7 e e
09-A73 34 IU e e
09-B08 70 32 e e
09-B09 IU IU e e
09-B36z 57 2
6
e
e
e
e
09-C54 38 IU e e
09-C77 IU 6 e e
09-D14 22 9 e e
10-D052 11 IU e e
10-D062 40 IU e e
10-D094 IU IU e e
10-D100 36 IU e e
10-D220 19 12 þ e
10-D226 56 IU e e
10-D234 32 4 þ e
10-D328 IU IU þ e
10-D342 33 6 e e
10-D375 32 IU þ e
10-D445 12 IU e e
10-D497 IU IU þ e
* Interval from the onset of illness to serum collection; yInformation was unav
isolate was designated as KNIH/2009/77. ELISAZ enzyme-linked immunosounclear. Travel destination of the cases was mainly
South East Asia including Indonesia, Malaysia, the
Philippines, Singapore, and Vietnam. The interval from
onset of illness to serum sampling in CHKIV ELISA-
positive cases was 4e32 days. As for two cases that
were positive in RT-PCR analysis, possibility of cross
contamination was excluded by sequence comparison
with laboratory reference strain Ross (GenBank ID:
AF490259).
3.2. Virus isolation and phylogenetic analysis
The two serum samples that were positive in RT-PCR
analysis were subjected to virus isolation and one isolate
was recovered from serum of a febrile patient (GenBank
ID: 09-B36) who returned from Malaysia and
Singapore. The isolate was further sequenced using
primer pairs covering E2, E1, and 30NS genes and
named as KNIH/2009/77 (GenBank ID: KC8110970).
The NCBI-BLAST search showed that the KNIH/2009/
77 isolate has 98e99% sequence similarity with CHIKV
isolates circulating in the South East Asia including
Malaysia, Singapore, and Thailand. Similar to CHIKVs
that have appeared since 2006 and had adaptive infec-
tivity to Ae. albopictus mosquitoes, KNIH/2009/77
showed a typical amino-acid substitution (alanine to
valine) at position 226 of the E1 protein (Figure 2). A
phylogenetic tree was constructed based on partial se-
quences of the E1 gene of CHIKV isolates. The KNIH/
2009/77 isolate was clustered within the Central/East/Chikungunya
Travel destinationCR ELISA RT-PCR
þ e Philippines
þ e Indonesia
þ e Indonesia
þ e Malaysia
e þ IU
e
þ
þ
e
Malaysia/Singapore
þ e IU
þ e Vietnam
þ e IU
þ e IU
þ e IU
þ e IU
þ e IU
þ e Indonesia
þ e IU
þ e Philippines
þ e East Timor
þ e IU
þ e Philippines
þ e IU
þ e Vietnam
ailable. z Virus was isolated from this patient’s acute-phase serum and the
rbent assay; RT-PCRZ reverse transcription-polymerase chain reaction.
Figure 2. The alignment of amino-acid sequences of the E1 gene of chikungunya viruses. Amino-acid sequence substitution from
alanine (A) to valine (V) was shown at the position 226. Country and isolation year are described in the parentheses of each virus
name. SAR Z South African Republic.
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from Malaysia and Singapore (Table 2, Figure 3).4. Discussion
In the present study, we investigated the extent of
CHIKV infections in dengue-suspected patients who
returned from travel. A total of 22 serum samples
showed evidence of travel-related CHIK during 2009
and 2010. It was revealed that 4.5 % (17/379) of dengue-
negative samples was CHIK-positive. Interestingly,
results of ELISA showed that 4.7% (5/107) of dengue-
positive cases were positive for CHIKV IgM in 2010.Table 2. Details of the chikungunya viruses used for phylogen
Strain name Geographic origin
Ross Tanzania
lbH35 Nigeria
PM2951 Senegal
18211 SAR
Ag41855 Uganda
DRC027 DRC
HD 180760 Senegal
MY/06/37348 Malaysia
0706aTw Taiwan
SL-CK1 Sri Lanka
MY/08/065 Malaysia
SGEHICHD122508 Singapore
LK(EH)CH19308 Sri Lanka
MY/08/2844 Malaysia
Mal2008 Malaysia
1510 Thailand
CHIK/SBY79/10 Indonesia
TN06410 India
IND-63-WB1 India
IND-73-MH5 India
AF15561 Thailand
DRC Z Democratic Republic of Congo; SAR Z South African Republic.Generally, ELISA is just a screening test and a confir-
matory testing such as plaque reduction neutralization
test (PRNT) should be performed for differentiating
CHIK and dengue. However, our laboratory had not set
up the method at that time and it remains to be resolved
later. We attempted to isolate the virus in the two RT-
PCR-positive cases and one was recovered successfully
from the serum collected within 2 days after onset of
illness. A CHIKV infection has been categorized as a
communicable disease group IV since late 2010 in South
Korea. This functioned as a passive patient surveillance
system based on compulsory case reporting by physi-
cians. Since enacting the law, however, the number of
requests for CHIK diagnosis from hospitals was only 25etic analysis
Sampling year GenBank ID
1953 AF490259
1964 AF192893
1966 AF192891
1976 AF192903
1982 AF192907
2000 AY549577
2005 HM045817
2006 FN295483
2007 EU192143
2007 HM045801
2008 FN295485
2008 FJ445502
2008 FJ513677
2008 FN295489
2008 GQ168719
2009 JN661154
2010 AB678694
2010 HM159389
Unknown EF027140
Unknown EF027141
Unknown EF452493
Figure 3. Phylogenetic analysis of the chikungunya virus based on the partial E1 gene (1044 nt) from 21 isolates. The tree was
constructed by the neighbor-joining method (substitution model: maximum composite likelihood) using MEGA (version 5.1). The
o’nyong-nyong virus (ONN, GenBank ID: AF079456) was used as out-group in the tree. The percentage of bootstrap values is
shown at each node (2000 replications). CESA Z Central/East/South African; DRC Z Democratic Republic of Congo;
SAR Z South African Republic.
174 G.W. Cha, et alcases by March 2013. It may be due to the low-level
recognition of the disease in the medical community.
From this viewpoint, the number of real CHIK might
have been underestimated in South Korea. It is hard to
differentiate dengue from CHIK with clinical symptoms
alone. Therefore, we recommend serological and mo-
lecular testing of CHIKV as well as dengue to diagnose
febrile patients who returned from tropical regions. It
was revealed that mutant viruses with amino-acid sub-
stitution (alanine to valine at position 226) at the E1
gene have superior infectivity in Ae. albopictus than Ae.
aegypti mosquitoes and are responsible for recent out-
breaks in India, Malaysia, and Singapore [15,17,18]. An
isolate, KNIH/2009/77, recovered in this study was also
a mutant-type CHIKV that may have the potential to
infect Ae. albopictus mosquitoes distributed in Korea.
The possibility of importation and spread of CHIKV by
acute febrile traveler was reported in 2007 in Italy [19].
Considering that Ae. albopictus mosquitoes are already
distributed in Korea, we could not exclude an abrupt
introduction of CHIKV as well as DENV.
In conclusion, we presented first evidence of travel-
associated CHIKV infections in South Korea. This
finding highlights the need to conduct laboratory and
vector surveillance program for CHIKV as well as an
urgent need to modify evidence-based travel health
policies and recommendations.Acknowledgments
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